Share on StockTwits

Equities researchers at Canaccord Genuity cut their price target on shares of Croda International Plc (LON:CRDA) from GBX 2,030 ($34.55) to GBX 1,950 ($33.19) in a research report issued on Wednesday. The firm currently has a “sell” rating on the stock. Canaccord Genuity’s price target indicates a potential downside of 10.88% from the company’s current price.

A number of other firms have also recently commented on CRDA. Analysts at Numis Securities Ltd cut their price target on shares of Croda International Plc from GBX 2,554 ($43.46) to GBX 2,248 ($38.26) in a research note on Wednesday. They now have a “hold” rating on the stock. Separately, analysts at Citigroup Inc. cut their price target on shares of Croda International Plc from GBX 2,100 ($35.74) to GBX 1,900 ($32.33) in a research note on Wednesday. They now have a “sell” rating on the stock. Finally, analysts at Liberum Capital downgraded shares of Croda International Plc to a “sell” rating in a research note on Tuesday. They now have a GBX 2,000 ($34.04) price target on the stock, down previously from GBX 2,500 ($42.55). Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of GBX 2,578.71 ($43.89).

Shares of Croda International Plc (LON:CRDA) traded down 3.75% during mid-day trading on Wednesday, hitting GBX 2106.00. The stock had a trading volume of 937,957 shares. Croda International Plc has a one year low of GBX 2095.00 and a one year high of GBX 2761.00. The stock’s 50-day moving average is GBX 2504.42 and its 200-day moving average is GBX 2469.61. The company’s market cap is £2.837 billion.

Croda International Plc is a marketing and technology company that produces and sells speciality chemicals.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.